Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter

被引:119
作者
Döring, F
Will, J
Amasheh, S
Clauss, W
Ahlbrecht, H
Daniel, H
机构
[1] Univ Giessen, Inst Nutr Sci, Mol Nutr Ctr, D-35392 Giessen, Germany
[2] Univ Giessen, Inst Anim Physiol, D-35392 Giessen, Germany
关键词
D O I
10.1074/jbc.273.36.23211
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proton-dependent electrogenic transporters for di- and tripeptides have been identified in bacteria, fungi, plants, and mammalian cells. They all show sequence-independent transport of all possible di- and tripeptides as well as of a variety of peptidomimetics, We used the mammalian intestinal peptide transporter PEPT1 as a model to define the molecular basis for its multisubstrate specificity. By employing computational analysis of possible substrate conformations in combination with transport assays using transgenic yeast cells and Xenopus laevis oocytes expressing PEPT1, the minimal structural requirements for substrate binding and transport were determined. Based on a series of medium chain fatty acids bearing an amino group as a head group (omega-amino fatty acids, omega-AFA), we show that electrogenic transport by PEPT1 requires as a minimum the two ionized head groups separated by at least four methylene groups. Consequently, a > 500 pm < 630 pm distance between the two charged centers (carboxylic carbon and amino nitrogen) is sufficient for substrate recognition and transport. Removal of either the amino group or the carboxyl group in omega-AFA maintained the affinity of the compound for interaction with the transporter but abolished the capability for electrogenic transport, Additional groups in the omega-AFA backbone that provide more hydrogen bonding sites appear to increase substrate affinity but are not essential. The information provided here does (a) explain the capability of the peptide carrier for sequence-independent transport of thousands of different substrates and (b) set the molecular basis for a rational drug design to increase the absorption of peptide-based drugs mediated by PEPT1.
引用
收藏
页码:23211 / 23218
页数:8
相关论文
共 27 条
[1]   Transport of charged dipeptides by the intestinal H+/peptide symporter PepT1 expressed in Xenopus laevis oocytes [J].
Amasheh, S ;
Wenzel, U ;
Boll, M ;
Dorn, D ;
Weber, WM ;
Clauss, W ;
Daniel, H .
JOURNAL OF MEMBRANE BIOLOGY, 1997, 155 (03) :247-256
[2]   EXPRESSION CLONING OF A CDNA FROM RABBIT SMALL-INTESTINE RELATED TO PROTON-COUPLED TRANSPORT OF PEPTIDES, BETA-LACTAM ANTIBIOTICS AND ACE-INHIBITORS [J].
BOLL, M ;
MARKOVICH, D ;
WEBER, WM ;
KORTE, H ;
DANIEL, H ;
MURER, H .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1994, 429 (01) :146-149
[3]   Evidence for the absolute conformational specificity of the intestinal H+/peptide symporter, PEPT1 [J].
Brandsch, M ;
Thunecke, F ;
Küllertz, G ;
Schutkowski, M ;
Fischer, G ;
Neubert, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :3861-3864
[4]   GENERAL PARAMETERIZED SCF MODEL FOR FREE-ENERGIES OF SOLVATION IN AQUEOUS-SOLUTION [J].
CRAMER, CJ ;
TRUHLAR, DG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (22) :8305-8311
[5]   AN SCF SOLVATION MODEL FOR THE HYDROPHOBIC EFFECT AND ABSOLUTE FREE-ENERGIES OF AQUEOUS SOLVATION [J].
CRAMER, CJ ;
TRUHLAR, DG .
SCIENCE, 1992, 256 (5054) :213-217
[6]   Function and molecular structure of brush border membrane peptide H+ symporters [J].
Daniel, H .
JOURNAL OF MEMBRANE BIOLOGY, 1996, 154 (03) :197-203
[7]   Cellular and molecular mechanisms of renal peptide transport [J].
Daniel, H ;
Herget, M .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (01) :F1-F8
[8]   Expression and functional characterization of the mammalian intestinal peptide transporter PepT1 in the methylotropic yeast Pichia pastoris [J].
Doring, F ;
Theis, S ;
Daniel, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (03) :656-662
[9]  
Doring F, 1996, J PHYSIOL-LONDON, V497, P773
[10]   Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications [J].
Döring, F ;
Walter, J ;
Will, J ;
Föcking, M ;
Boll, M ;
Amasheh, S ;
Clauss, W ;
Daniel, H .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2761-2767